Leads key partnerships with academic institutions and network groups in guideline-enabling clinical trials supporting Signatera reimbursement and clinical adoption. This individual will leverage their scientific background in oncology alongside comprehensive commercial awareness of the precision oncology landscape and business acumen to bring MRD testing to oncology patients.